Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
418.4 DKK | +1.01% | +9.07% | +12.75% |
05-03 | Transcript : Novozymes A/S, Q1 2024 Sales/ Trading Statement Call, May 03, 2024 | |
05-03 | Novonesis Provides Sales Guidance for the Year 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+12.75% | 28.01B | |
-1.95% | 4.45B | |
+11.90% | 1.75B | |
-11.00% | 608M | |
-8.19% | 504M | |
-15.14% | 110M | |
-11.41% | 53.41M |
- Stock Market
- Equities
- NSIS B Stock
- News Novonesis A/S
- Novozymes, Chr. Hansen’s Proposed Merger Secures All Regulatory Approvals